Nov 7 Statement |
UMR Congratulates Dr. Monica Bertagnolli on her Confirmation as the next NIH Director
Why Invest in NIH Research? |
UMR Offers Fact Sheets
Explaining Why Congress Must #keepNIHstrong
Labcorp, PerkinElmer latest to target COVID-flu combo test market
BD has a point-of-care antigen test, which received FDA emergency use authorization in March, that can rapidly test for both COVID-19 and influenza at the same time providing results in 15 minutes, as well as a PCR test that can be used in hospital laboratories.